Trials / Completed
CompletedNCT00569426
Evaluating the Use of Two Different Needles in Subjects With Diabetes
An Open-label, Randomised, Multi-centre Cross-over Trial in Diabetes Patients Evaluating Preference, Injection Pressure, Pain Perception and Handling When Injections Are Performed With Two Different Needles i.e. NovoFine® 32 Gauge Tip x 6mm and NovoFine® 30 Gauge x 8mm Using a FlexPen® Disposable Insulin Injection Pen
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe. The aim of this trial is to compare two needle types when used with a disposable insulin injection pen in the everyday life setting of an insulin treated patient with diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovoFine® needle 6 mm | |
| DEVICE | NovoFine® needle 8 mm |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2007-12-07
- Last updated
- 2017-01-19
Locations
10 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00569426. Inclusion in this directory is not an endorsement.